NCT02508441 2018-10-18Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid TumorsAndes BiotechnologiesPhase 1 Terminated22 enrolled
NCT00088023 2014-03-31Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of EffectivenessSpectrum Pharmaceuticals, IncPhase 1 Terminated40 enrolled